MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Hyperkinetic movement disorder following Covid: A Temporal corelation or Coincidental ?

    GP. Burman (Hisar, India)

    Objective: Hypokinetic movement disorder and parkinsonian like picture has been well described in literature but hyperkinetic movements are extremely rare and less highlighted in global…
  • 2022 International Congress

    Quality of Life in African American and White Parkinson’s Disease Patients

    D. Hall, S. Anderson, G. Stebbins, L. Barnes, M. Bailey, L. Shulman (Chicago, USA)

    Objective: To determine the quality of life of African American (AA) and White patients with Parkinson’s disease (PD) at the Rush University Medical Center (RUMC)…
  • 2022 International Congress

    Turning during single and dual tasking in Parkinson’s Disease

    E. Bianchini, E. Warmerdam, R. Romijnders, J. Hoffmann, G. Schmidt, F. Pontieri, C. Hansen, W. Maetzler (Rome, Italy)

    Objective: To investigate turning kinematics and intersegmental coordination in single (ST) and dual tasking (DT) in Parkinson’s Disease (PD) patients. Background: Successful turning depends on…
  • 2022 International Congress

    Changes in the level of glial neurotrophic factor in Parkinson’s disease depending on the form

    B. Muminov, R. Matmurodov, E. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) depending on the form Background: Neurotrophic factors…
  • 2022 International Congress

    Validation of the PD Home Diary for Assessment of Motor Fluctuations in Advanced Parkinson’s Disease

    M. Löhle, A. Bremer, F. Gandor, J. Timpka, P. Odin, G. Ebersbach, A. Storch (Rostock, Germany)

    Objective: To determine the validity of the Parkinson’s disease (PD) home diary for quantification of motor states in patients with advanced PD and motor fluctuations.…
  • 2022 International Congress

    VALIDATING ACCELEROMETRY AS A MEASURE OF ENERGY EXPENDITURE AND PHYSICAL ACTIVITY IN ADULTS WITH HUNTINGTON’S DISEASE

    L. Simón, E. Cubo, J. Rivadeneyra, C. Collazo, M. Soto, J. Raya, D. Castillo, S. Calvo, A. Fernández (Burgos, Spain)

    Objective: to validate the use of accelerometers to quantify energy expenditure (EE) under controlled conditions for Huntington’s disease (HD) patients using Indirect Calorimetry (IC) as…
  • 2022 International Congress

    Levodopa–entacapone–carbidopa intestinal gel infusion for advanced Parkinson’s disease patients – data from a Romanian center

    A. Dulamea, T. Barbulescu, C. Banica (Bucharest, Romania)

    Objective: To report the experience with levodopa–entacapone–carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson’s disease (PD) from a Romanian center. Background: LECIG…
  • 2022 International Congress

    The role of intraoperative electrophysiological monitoring in implanting globus pallidus internus electrodes in patients with dystonia

    J. Kunst, D. Hrabovsky, T. Jurkova, J. Chrastina, M. Balaz (Brno, Czech Republic)

    Objective: The first aim was to compare the preplanned GPi electrode neuroradiological trajectory with the final trajectory selected after electrophysiological monitoring. The second aim was…
  • 2022 International Congress

    Affected tongue movements in idiopathic REM sleep behavior disorder

    T. Thies, N. Geerts, D. Mücke, A. Seger, M. Barbe, M. Sommerauer (Cologne, Germany)

    Objective: In Parkinson’s disease (PD), recognition of speech deviations often follows clinical diagnosis. But what if speech is a prodromal biomarker in PD? The study…
  • 2022 International Congress

    A Randomized, Wait-List Controlled Trial of the Feasibility and Efficacy of Small Group Online-based Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease

    N. Nishikawa, T. Hatano, C. Uchida, Y. Ouji, N. Miyamoto, G. Oyama, N. Hattori (Tokyo, Japan)

    Objective: To investigate the feasibility and efficacy of online-based Cognitive Behavioral Therapy (CBT) for anxiety in Parkinson's disease (PD). Background: Anxiety symptoms in Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 655
  • 656
  • 657
  • 658
  • 659
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley